Global brain health—the time to act is now

Published on March 18, 2024

The recently published 2021 Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) data on neurological disorders represents a comprehensive analysis of 37 neurological conditions, amounting to a staggering 443 million disability-adjusted life-years (DALYs) affecting 43·1% of the global population. The ten leading conditions, in descending order, are stroke, neonatal encephalopathy, migraine, dementias, diabetic neuropathy, meningitis, idiopathic epilepsy, neurological complications from preterm birth, autism spectrum disorder, and nervous system cancer. Interestingly, data disaggregation shows that the burden of neurological disorders lies largely with low-income and middle-income countries (LMICs). In addition, the 2019 global burden of psychiatric disorders was estimated at 125 million DALYs.

Continue reading

Other news

Community engagement to mitigate antimicrobial resistance in low-and middle-income countries – an essential strategy for implementation of national action plans on AMR

March 18, 2024
Antimicrobial Resistance (AMR) is a significant cause of mortality and morbidity, responsible for 1.27 million deaths worldwide in 2019 alone. The impact of AMR is multi-dimensional, resulting in poor health outcomes, increased healthcare expenditure, and affecting food production. The drivers of AMR are diverse and multisectoral. Inappropriate use of antimicrobials in human health, veterinary sec

Association Between Social Vulnerability and Streptococcus pneumoniae Antimicrobial Resistance in US Adults

March 19, 2024
Background: Growing evidence indicates antimicrobial resistance disproportionately affects individuals living in socially vulnerable areas. This study evaluated the association between Streptococcus pneumoniae (SP) antimicrobial resistance (AMR) and the CDC/ATSDR Social Vulnerability Index (SVI) in the United States.Methods: Adult patients ≥ 18 years with 30-day nonduplicate SP isolates from ambul